CINC Insider Trading Activity and SEC Form 4 Filings
CINC insider trading summary
No open-market insider purchases or sales of CinCor Pharma, Inc. (CINC) have been reported on SEC Form 4 in the past 12 months.
Latest CINC insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 28, 2022 | Sofinnova Management X, L.P. | 10% Owner | Sell | $86K (6,000 @ $14.32) |
| Nov 28, 2022 | Sofinnova Venture Partners X, L.P. | 10% Owner | Sell | $86K (6,000 @ $14.32) |
| Nov 28, 2022 | Maha Katabi | 10% Owner | Sell | $86K (6,000 @ $14.32) |
| Nov 28, 2022 | Sofinnova Management X-A, L.L.C. | 10% Owner | Sell | $86K (6,000 @ $14.32) |
| Nov 28, 2022 | James Healy | Director | Sell | $86K (6,000 @ $14.32) |
| Aug 15, 2022 | 5AM Partners VI, LLC | 10% Owner | Buy | $3.4M (112,667 @ $30.00) |
| Aug 15, 2022 | 5AM Ventures VI, L.P. | 10% Owner | Buy | $14.6M (487,333 @ $30.00) |
| Aug 15, 2022 | 5AM Ventures VI, L.P. | 10% Owner | Buy | $3.4M (112,667 @ $30.00) |
| Aug 15, 2022 | 5AM Opportunities II, L.P. | 10% Owner | Buy | $14.6M (487,333 @ $30.00) |
| Aug 15, 2022 | Sofinnova Partners SAS | 10% Owner | Buy | $4.0M (133,333 @ $30.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.